Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 138 | 2024 | 3220 | 11.950 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 31 | 2024 | 556 | 5.830 |
Why?
|
Atrophy | 69 | 2024 | 1633 | 5.090 |
Why?
|
Magnetic Resonance Imaging | 176 | 2024 | 36426 | 4.190 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 20 | 2023 | 254 | 3.270 |
Why?
|
Brain | 108 | 2024 | 27112 | 3.120 |
Why?
|
Spinal Cord | 25 | 2020 | 1818 | 2.670 |
Why?
|
Disability Evaluation | 30 | 2024 | 1835 | 1.730 |
Why?
|
Meninges | 4 | 2019 | 198 | 1.280 |
Why?
|
Disease Progression | 30 | 2022 | 13506 | 0.900 |
Why?
|
Immunologic Factors | 6 | 2021 | 1589 | 0.870 |
Why?
|
Adult | 155 | 2024 | 221177 | 0.870 |
Why?
|
Nerve Fibers, Myelinated | 7 | 2011 | 952 | 0.860 |
Why?
|
Severity of Illness Index | 22 | 2021 | 15842 | 0.810 |
Why?
|
Image Interpretation, Computer-Assisted | 14 | 2019 | 3357 | 0.790 |
Why?
|
Fatigue | 10 | 2021 | 1552 | 0.790 |
Why?
|
Brain Diseases | 10 | 2006 | 1545 | 0.780 |
Why?
|
Image Processing, Computer-Assisted | 26 | 2024 | 9000 | 0.780 |
Why?
|
Cerebral Cortex | 11 | 2020 | 5777 | 0.760 |
Why?
|
Immunosuppressive Agents | 6 | 2020 | 4174 | 0.760 |
Why?
|
Middle Aged | 125 | 2024 | 220895 | 0.740 |
Why?
|
Demyelinating Diseases | 8 | 2023 | 351 | 0.720 |
Why?
|
Positron-Emission Tomography | 7 | 2024 | 6485 | 0.720 |
Why?
|
Toluidines | 1 | 2020 | 21 | 0.710 |
Why?
|
Crotonates | 1 | 2020 | 21 | 0.710 |
Why?
|
Nervous System Diseases | 5 | 2011 | 1666 | 0.690 |
Why?
|
Diagnostic Imaging | 7 | 2011 | 3530 | 0.680 |
Why?
|
Male | 162 | 2024 | 360804 | 0.660 |
Why?
|
Adjuvants, Immunologic | 5 | 2016 | 1036 | 0.640 |
Why?
|
Humans | 237 | 2024 | 761504 | 0.630 |
Why?
|
Female | 153 | 2024 | 392644 | 0.620 |
Why?
|
Thalamus | 8 | 2018 | 1045 | 0.620 |
Why?
|
Cognition Disorders | 10 | 2020 | 3979 | 0.590 |
Why?
|
Neurofilament Proteins | 5 | 2023 | 336 | 0.570 |
Why?
|
Iron | 6 | 2009 | 1793 | 0.560 |
Why?
|
Organ Size | 8 | 2019 | 2254 | 0.540 |
Why?
|
Fluorine Radioisotopes | 1 | 2019 | 418 | 0.540 |
Why?
|
Receptors, GABA | 1 | 2017 | 313 | 0.510 |
Why?
|
Cerebrospinal Fluid | 4 | 2011 | 544 | 0.510 |
Why?
|
Sample Size | 2 | 2017 | 841 | 0.500 |
Why?
|
Diffusion Magnetic Resonance Imaging | 8 | 2021 | 2790 | 0.490 |
Why?
|
Meningitis | 1 | 2017 | 217 | 0.490 |
Why?
|
Gadolinium | 12 | 2020 | 960 | 0.460 |
Why?
|
Imaging, Three-Dimensional | 9 | 2019 | 4063 | 0.460 |
Why?
|
Quality of Life | 12 | 2021 | 13367 | 0.450 |
Why?
|
Neuropsychological Tests | 17 | 2020 | 7045 | 0.440 |
Why?
|
Sensitivity and Specificity | 25 | 2018 | 14666 | 0.430 |
Why?
|
Radiopharmaceuticals | 3 | 2018 | 2651 | 0.430 |
Why?
|
Cerebral Ventricles | 6 | 2007 | 542 | 0.420 |
Why?
|
Image Enhancement | 15 | 2020 | 2885 | 0.420 |
Why?
|
Microglia | 2 | 2020 | 1361 | 0.410 |
Why?
|
Encephalomyelitis, Acute Disseminated | 2 | 2003 | 68 | 0.400 |
Why?
|
Central Nervous System | 4 | 2014 | 1336 | 0.390 |
Why?
|
MicroRNAs | 2 | 2019 | 3816 | 0.390 |
Why?
|
Cerebrovascular Disorders | 3 | 2009 | 1474 | 0.390 |
Why?
|
Reproducibility of Results | 28 | 2022 | 20098 | 0.380 |
Why?
|
Cervical Vertebrae | 2 | 2015 | 980 | 0.370 |
Why?
|
Glial Fibrillary Acidic Protein | 6 | 2023 | 553 | 0.370 |
Why?
|
Optic Nerve | 2 | 2020 | 572 | 0.370 |
Why?
|
Interferon-beta | 7 | 2011 | 345 | 0.360 |
Why?
|
Substantia Nigra | 3 | 2020 | 350 | 0.360 |
Why?
|
Intracranial Embolism and Thrombosis | 3 | 1999 | 144 | 0.360 |
Why?
|
Contrast Media | 11 | 2009 | 5311 | 0.360 |
Why?
|
Meningitis, Bacterial | 3 | 2004 | 221 | 0.350 |
Why?
|
Reference Values | 9 | 2011 | 4920 | 0.350 |
Why?
|
Tomography, Emission-Computed | 4 | 2004 | 1122 | 0.350 |
Why?
|
Editorial Policies | 1 | 2015 | 458 | 0.340 |
Why?
|
Pilot Projects | 8 | 2022 | 8631 | 0.340 |
Why?
|
Young Adult | 23 | 2021 | 59243 | 0.340 |
Why?
|
Bone Marrow Transplantation | 2 | 2010 | 2693 | 0.340 |
Why?
|
Neuroprotective Agents | 1 | 2016 | 957 | 0.340 |
Why?
|
Iron Metabolism Disorders | 2 | 2007 | 24 | 0.330 |
Why?
|
Neurology | 2 | 2011 | 780 | 0.330 |
Why?
|
Employment | 2 | 2015 | 1118 | 0.320 |
Why?
|
Artifacts | 6 | 2016 | 1911 | 0.320 |
Why?
|
Caudate Nucleus | 4 | 2009 | 389 | 0.310 |
Why?
|
Algorithms | 11 | 2024 | 14031 | 0.310 |
Why?
|
Thrombolytic Therapy | 5 | 2009 | 2064 | 0.300 |
Why?
|
Publishing | 1 | 2015 | 833 | 0.290 |
Why?
|
Dynorphins | 4 | 1992 | 82 | 0.280 |
Why?
|
Spinal Cord Neoplasms | 2 | 2001 | 263 | 0.280 |
Why?
|
Cerebral Veins | 3 | 2008 | 157 | 0.280 |
Why?
|
Sarcoidosis | 3 | 2002 | 521 | 0.280 |
Why?
|
Pregnancy Complications | 1 | 2020 | 2947 | 0.270 |
Why?
|
Neurodegenerative Diseases | 2 | 2007 | 1087 | 0.270 |
Why?
|
Cohort Studies | 15 | 2021 | 41487 | 0.270 |
Why?
|
Mitoxantrone | 1 | 2006 | 148 | 0.270 |
Why?
|
Cerebral Infarction | 6 | 2001 | 983 | 0.260 |
Why?
|
Optic Neuritis | 1 | 2008 | 174 | 0.250 |
Why?
|
Retrospective Studies | 27 | 2024 | 80636 | 0.250 |
Why?
|
Tomography, X-Ray Computed | 16 | 2009 | 20570 | 0.250 |
Why?
|
Mental Processes | 2 | 2006 | 244 | 0.250 |
Why?
|
Leadership | 1 | 2015 | 1385 | 0.250 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 2 | 2021 | 38 | 0.250 |
Why?
|
Longitudinal Studies | 13 | 2020 | 14605 | 0.240 |
Why?
|
Nerve Degeneration | 3 | 2014 | 748 | 0.240 |
Why?
|
Neurotoxicity Syndromes | 1 | 2008 | 301 | 0.240 |
Why?
|
Predictive Value of Tests | 16 | 2020 | 15266 | 0.230 |
Why?
|
Toxoplasmosis, Cerebral | 1 | 2004 | 19 | 0.230 |
Why?
|
Third Ventricle | 5 | 2007 | 74 | 0.230 |
Why?
|
Spinal Cord Diseases | 3 | 2019 | 292 | 0.230 |
Why?
|
Meningitis, Viral | 1 | 2004 | 50 | 0.220 |
Why?
|
Periodicals as Topic | 1 | 2015 | 1463 | 0.220 |
Why?
|
Magnetic Resonance Angiography | 4 | 2008 | 1432 | 0.220 |
Why?
|
Statistics, Nonparametric | 4 | 2017 | 2850 | 0.220 |
Why?
|
Leukoencephalitis, Acute Hemorrhagic | 1 | 2003 | 19 | 0.220 |
Why?
|
Glia Maturation Factor | 1 | 2022 | 13 | 0.210 |
Why?
|
Depression | 6 | 2021 | 8124 | 0.210 |
Why?
|
Subtraction Technique | 3 | 2011 | 512 | 0.210 |
Why?
|
AIDS Dementia Complex | 1 | 2004 | 153 | 0.210 |
Why?
|
Familial Mediterranean Fever | 1 | 2023 | 65 | 0.210 |
Why?
|
Syncope | 1 | 2005 | 427 | 0.210 |
Why?
|
Cephalometry | 1 | 2004 | 382 | 0.210 |
Why?
|
Hematoma, Subdural, Chronic | 1 | 2004 | 95 | 0.210 |
Why?
|
Cerebral Arteries | 3 | 2000 | 490 | 0.200 |
Why?
|
Encephalitis | 4 | 1999 | 438 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.200 |
Why?
|
Neuromyelitis Optica | 1 | 2006 | 263 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.200 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2002 | 2010 | 0.200 |
Why?
|
Cerebellar Diseases | 3 | 1999 | 220 | 0.200 |
Why?
|
Putamen | 2 | 2017 | 292 | 0.200 |
Why?
|
Brain Mapping | 7 | 2008 | 6630 | 0.200 |
Why?
|
Metabolic Diseases | 1 | 2008 | 683 | 0.200 |
Why?
|
Corpus Striatum | 2 | 2014 | 1235 | 0.190 |
Why?
|
Globus Pallidus | 2 | 2017 | 250 | 0.190 |
Why?
|
Striatonigral Degeneration | 1 | 2001 | 13 | 0.190 |
Why?
|
Dextrorphan | 2 | 1992 | 4 | 0.190 |
Why?
|
Receptors, Opioid | 2 | 1992 | 145 | 0.190 |
Why?
|
Echo-Planar Imaging | 1 | 2005 | 663 | 0.180 |
Why?
|
Medial Forebrain Bundle | 1 | 2021 | 43 | 0.180 |
Why?
|
Inflammation | 5 | 2024 | 10773 | 0.180 |
Why?
|
Opportunistic Infections | 1 | 2004 | 376 | 0.180 |
Why?
|
Mood Disorders | 2 | 2005 | 1127 | 0.180 |
Why?
|
Acetanilides | 2 | 2020 | 169 | 0.180 |
Why?
|
Trigeminal Neuralgia | 1 | 2001 | 107 | 0.180 |
Why?
|
Gadolinium DTPA | 5 | 2007 | 823 | 0.170 |
Why?
|
Hydroxybutyrates | 1 | 2020 | 79 | 0.170 |
Why?
|
Cerebral Hemorrhage | 4 | 2008 | 2656 | 0.170 |
Why?
|
Fatal Outcome | 6 | 2006 | 1834 | 0.170 |
Why?
|
Acute Disease | 9 | 2003 | 7237 | 0.170 |
Why?
|
Receptors, Neurotransmitter | 2 | 1990 | 174 | 0.170 |
Why?
|
Head | 1 | 2005 | 924 | 0.170 |
Why?
|
Personality Disorders | 1 | 2004 | 722 | 0.170 |
Why?
|
Cerebral Angiography | 3 | 2008 | 1281 | 0.160 |
Why?
|
Headache | 3 | 2007 | 1256 | 0.160 |
Why?
|
Arachnoid | 2 | 2000 | 50 | 0.160 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2004 | 686 | 0.160 |
Why?
|
Toluene | 1 | 1998 | 32 | 0.160 |
Why?
|
Biological Assay | 2 | 2020 | 626 | 0.160 |
Why?
|
Intermediate Filaments | 3 | 2023 | 172 | 0.160 |
Why?
|
Intracranial Hypotension | 1 | 1999 | 42 | 0.160 |
Why?
|
Phosphatidylcholines | 1 | 2020 | 405 | 0.160 |
Why?
|
Brain Neoplasms | 6 | 2002 | 9031 | 0.160 |
Why?
|
Hypertension, Malignant | 1 | 1998 | 17 | 0.150 |
Why?
|
Pia Mater | 2 | 2000 | 87 | 0.150 |
Why?
|
Paralysis | 2 | 1990 | 250 | 0.150 |
Why?
|
Pyramidal Tracts | 1 | 2020 | 252 | 0.150 |
Why?
|
Diagnosis, Differential | 12 | 2005 | 12974 | 0.150 |
Why?
|
Cerebral Ventriculography | 1 | 1997 | 44 | 0.150 |
Why?
|
Neuroglia | 1 | 2024 | 956 | 0.150 |
Why?
|
Memory Disorders | 1 | 2005 | 1198 | 0.150 |
Why?
|
Empyema | 1 | 1997 | 41 | 0.150 |
Why?
|
Recurrence | 6 | 2020 | 8465 | 0.150 |
Why?
|
Urokinase-Type Plasminogen Activator | 3 | 2006 | 325 | 0.150 |
Why?
|
Sagittal Sinus Thrombosis | 3 | 2002 | 11 | 0.150 |
Why?
|
Temporal Lobe | 1 | 2005 | 1695 | 0.150 |
Why?
|
Prospective Studies | 14 | 2023 | 54425 | 0.150 |
Why?
|
Puerperal Disorders | 1 | 2020 | 299 | 0.150 |
Why?
|
Diphtheria Toxoid | 1 | 1997 | 26 | 0.150 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 1999 | 130 | 0.140 |
Why?
|
Polyradiculoneuropathy | 1 | 1997 | 65 | 0.140 |
Why?
|
Hemangioblastoma | 1 | 1997 | 62 | 0.140 |
Why?
|
Regression Analysis | 6 | 2007 | 6343 | 0.140 |
Why?
|
Solvents | 1 | 1998 | 295 | 0.140 |
Why?
|
Lipoma | 1 | 1999 | 293 | 0.140 |
Why?
|
Injections, Intramuscular | 2 | 2016 | 554 | 0.140 |
Why?
|
Monitoring, Physiologic | 1 | 2005 | 1779 | 0.140 |
Why?
|
Spinal Puncture | 1 | 1999 | 282 | 0.140 |
Why?
|
Dura Mater | 1 | 1999 | 290 | 0.140 |
Why?
|
Nervous System | 1 | 2000 | 545 | 0.140 |
Why?
|
Memory | 2 | 2006 | 2188 | 0.140 |
Why?
|
Wine | 1 | 2017 | 166 | 0.140 |
Why?
|
Myelitis, Transverse | 1 | 1996 | 40 | 0.140 |
Why?
|
Tetanus Toxoid | 1 | 1997 | 189 | 0.140 |
Why?
|
Cerebellum | 2 | 2001 | 1501 | 0.140 |
Why?
|
von Hippel-Lindau Disease | 1 | 1997 | 151 | 0.130 |
Why?
|
Sumatriptan | 1 | 1996 | 66 | 0.130 |
Why?
|
Stroke | 4 | 2023 | 9757 | 0.130 |
Why?
|
Occipital Lobe | 1 | 1998 | 374 | 0.130 |
Why?
|
Pattern Recognition, Automated | 5 | 2018 | 997 | 0.130 |
Why?
|
Models, Statistical | 5 | 2016 | 5079 | 0.130 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2018 | 220 | 0.130 |
Why?
|
Disabled Persons | 3 | 2005 | 1225 | 0.130 |
Why?
|
Aged | 34 | 2020 | 169289 | 0.130 |
Why?
|
Serotonin Receptor Agonists | 1 | 1996 | 151 | 0.130 |
Why?
|
Drug Therapy, Combination | 3 | 2005 | 6310 | 0.120 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2002 | 1374 | 0.120 |
Why?
|
Nitriles | 1 | 2020 | 971 | 0.120 |
Why?
|
Automation | 1 | 2017 | 586 | 0.120 |
Why?
|
Frontal Lobe | 2 | 2007 | 1420 | 0.120 |
Why?
|
Treatment Outcome | 14 | 2017 | 64680 | 0.120 |
Why?
|
Parietal Lobe | 1 | 2000 | 852 | 0.120 |
Why?
|
Endocarditis, Bacterial | 1 | 1999 | 436 | 0.120 |
Why?
|
Vaccination | 3 | 2022 | 3384 | 0.120 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26125 | 0.120 |
Why?
|
Adolescent | 17 | 2020 | 88319 | 0.120 |
Why?
|
Anticonvulsants | 1 | 2004 | 1906 | 0.120 |
Why?
|
Prognosis | 9 | 2020 | 29625 | 0.120 |
Why?
|
RNA, Messenger | 2 | 2021 | 12795 | 0.120 |
Why?
|
Linear Models | 3 | 2017 | 5871 | 0.110 |
Why?
|
Genes, Reporter | 1 | 2018 | 1529 | 0.110 |
Why?
|
Glycolipids | 1 | 2014 | 206 | 0.110 |
Why?
|
Vaccines | 1 | 2022 | 844 | 0.110 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2021 | 822 | 0.110 |
Why?
|
Restless Legs Syndrome | 1 | 1996 | 233 | 0.110 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 1996 | 489 | 0.110 |
Why?
|
Hypoglycemia | 1 | 2000 | 883 | 0.110 |
Why?
|
Aging | 3 | 2021 | 8708 | 0.110 |
Why?
|
Nerve Regeneration | 1 | 2019 | 795 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 2019 | 3769 | 0.110 |
Why?
|
Pituitary Neoplasms | 2 | 1999 | 1324 | 0.110 |
Why?
|
Galactosyltransferases | 1 | 2014 | 276 | 0.110 |
Why?
|
Follow-Up Studies | 7 | 2017 | 39106 | 0.100 |
Why?
|
Fluoxetine | 1 | 1996 | 733 | 0.100 |
Why?
|
Naltrexone | 2 | 1992 | 317 | 0.100 |
Why?
|
Computational Biology | 1 | 2024 | 3518 | 0.100 |
Why?
|
Sinus Thrombosis, Intracranial | 2 | 2006 | 110 | 0.100 |
Why?
|
Cognition | 6 | 2020 | 6990 | 0.100 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1136 | 0.100 |
Why?
|
Spinal Cord Injuries | 2 | 2008 | 925 | 0.100 |
Why?
|
N-Methylaspartate | 1 | 1992 | 231 | 0.100 |
Why?
|
Longevity | 1 | 2019 | 1065 | 0.090 |
Why?
|
Autoantibodies | 1 | 2020 | 2116 | 0.090 |
Why?
|
Postpartum Period | 1 | 2018 | 1173 | 0.090 |
Why?
|
Motor Activity | 2 | 1992 | 2715 | 0.090 |
Why?
|
Seizures | 1 | 2004 | 2957 | 0.090 |
Why?
|
Case-Control Studies | 6 | 2011 | 22176 | 0.090 |
Why?
|
Venous Thrombosis | 3 | 2008 | 1303 | 0.090 |
Why?
|
Lymphocytes | 1 | 2019 | 2612 | 0.090 |
Why?
|
Aged, 80 and over | 14 | 2020 | 58976 | 0.090 |
Why?
|
Ultrasonography | 2 | 2003 | 5972 | 0.090 |
Why?
|
Physicians | 1 | 2008 | 4591 | 0.090 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 4853 | 0.090 |
Why?
|
Kynurenic Acid | 1 | 1990 | 44 | 0.090 |
Why?
|
Morphinans | 1 | 1990 | 27 | 0.090 |
Why?
|
Time Factors | 9 | 2020 | 39967 | 0.090 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2628 | 0.090 |
Why?
|
Neurons | 2 | 2022 | 9463 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2759 | 0.090 |
Why?
|
Cannabis | 1 | 1996 | 441 | 0.090 |
Why?
|
Curriculum | 1 | 2003 | 3743 | 0.080 |
Why?
|
Dementia | 2 | 2007 | 2686 | 0.080 |
Why?
|
HIV Infections | 3 | 2007 | 17351 | 0.080 |
Why?
|
Monocytes | 1 | 2019 | 2570 | 0.080 |
Why?
|
Rats, Inbred Strains | 4 | 1992 | 2088 | 0.080 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2009 | 141 | 0.080 |
Why?
|
Fatty Acids, Nonesterified | 1 | 1990 | 393 | 0.080 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2004 | 357 | 0.080 |
Why?
|
Influenza Vaccines | 1 | 1996 | 768 | 0.080 |
Why?
|
Memory, Short-Term | 2 | 2023 | 982 | 0.080 |
Why?
|
Brain Injuries | 1 | 2000 | 2053 | 0.080 |
Why?
|
Basal Ganglia | 4 | 2009 | 554 | 0.080 |
Why?
|
Lactosylceramides | 2 | 2020 | 15 | 0.080 |
Why?
|
Fuzzy Logic | 1 | 2007 | 57 | 0.070 |
Why?
|
Orbital Diseases | 2 | 2000 | 178 | 0.070 |
Why?
|
Antiphospholipid Syndrome | 1 | 2009 | 165 | 0.070 |
Why?
|
Psychomotor Performance | 2 | 2007 | 1881 | 0.070 |
Why?
|
Florida | 1 | 2009 | 431 | 0.070 |
Why?
|
Registries | 3 | 2021 | 8224 | 0.070 |
Why?
|
Perfusion Imaging | 1 | 2009 | 196 | 0.070 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2009 | 281 | 0.070 |
Why?
|
Intracranial Thrombosis | 1 | 2008 | 108 | 0.070 |
Why?
|
Cerebellar Ataxia | 2 | 1999 | 150 | 0.070 |
Why?
|
Cellulose | 1 | 2007 | 118 | 0.070 |
Why?
|
Medulla Oblongata | 1 | 2008 | 248 | 0.070 |
Why?
|
Space Perception | 3 | 2007 | 465 | 0.070 |
Why?
|
Sigmoidoscopy | 1 | 2007 | 151 | 0.070 |
Why?
|
Glycine | 1 | 1990 | 663 | 0.070 |
Why?
|
Thoracic Vertebrae | 2 | 2009 | 597 | 0.070 |
Why?
|
Astrocytes | 1 | 2014 | 1346 | 0.070 |
Why?
|
Cranial Sinuses | 1 | 2006 | 68 | 0.070 |
Why?
|
Analysis of Variance | 4 | 2009 | 6228 | 0.070 |
Why?
|
Statistics as Topic | 3 | 2014 | 2358 | 0.070 |
Why?
|
Pyrimidines | 1 | 2018 | 3028 | 0.070 |
Why?
|
Neutrophils | 1 | 2019 | 3767 | 0.070 |
Why?
|
Diffusion | 1 | 2008 | 814 | 0.060 |
Why?
|
Verbal Learning | 2 | 2007 | 463 | 0.060 |
Why?
|
Observer Variation | 3 | 2018 | 2606 | 0.060 |
Why?
|
Photography | 1 | 2008 | 532 | 0.060 |
Why?
|
Tissue Distribution | 2 | 2007 | 2265 | 0.060 |
Why?
|
Logistic Models | 4 | 2019 | 13255 | 0.060 |
Why?
|
Classification | 1 | 2005 | 127 | 0.060 |
Why?
|
Anti-Infective Agents, Local | 1 | 2007 | 247 | 0.060 |
Why?
|
Magnetics | 1 | 2008 | 599 | 0.060 |
Why?
|
Ophthalmology | 1 | 1991 | 550 | 0.060 |
Why?
|
Area Under Curve | 1 | 2009 | 1638 | 0.060 |
Why?
|
Amino Acids | 1 | 1990 | 1718 | 0.060 |
Why?
|
Mathematical Computing | 1 | 2004 | 142 | 0.060 |
Why?
|
Information Management | 1 | 2005 | 100 | 0.060 |
Why?
|
Syndrome | 3 | 2003 | 3267 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4028 | 0.060 |
Why?
|
Organometallic Compounds | 2 | 1999 | 647 | 0.060 |
Why?
|
New England | 2 | 2021 | 1054 | 0.060 |
Why?
|
Phenotype | 2 | 2014 | 16591 | 0.060 |
Why?
|
Injections, Intravenous | 1 | 2006 | 1379 | 0.060 |
Why?
|
Euphoria | 1 | 2004 | 65 | 0.060 |
Why?
|
Tuberculoma, Intracranial | 1 | 2003 | 8 | 0.060 |
Why?
|
User-Computer Interface | 2 | 2007 | 1400 | 0.060 |
Why?
|
Radionuclide Imaging | 2 | 2022 | 1972 | 0.050 |
Why?
|
Toxoplasmosis | 1 | 2004 | 94 | 0.050 |
Why?
|
Amantadine | 1 | 2003 | 57 | 0.050 |
Why?
|
Placebos | 1 | 2008 | 1667 | 0.050 |
Why?
|
Multicenter Studies as Topic | 2 | 2019 | 1702 | 0.050 |
Why?
|
Retinal Artery Occlusion | 1 | 2003 | 77 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2006 | 13639 | 0.050 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2003 | 75 | 0.050 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2004 | 133 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 3 | 2019 | 2400 | 0.050 |
Why?
|
Intelligence Tests | 1 | 2004 | 503 | 0.050 |
Why?
|
Urodynamics | 1 | 2004 | 346 | 0.050 |
Why?
|
Pregnancy | 3 | 2020 | 29874 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3416 | 0.050 |
Why?
|
Rectum | 1 | 2007 | 892 | 0.050 |
Why?
|
Meningitis, Meningococcal | 1 | 2002 | 43 | 0.050 |
Why?
|
Red Nucleus | 1 | 2002 | 11 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5709 | 0.050 |
Why?
|
Behavioral Symptoms | 1 | 2004 | 186 | 0.050 |
Why?
|
Mitochondrial Encephalomyopathies | 1 | 2002 | 40 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2014 | 4414 | 0.050 |
Why?
|
Animals | 11 | 2021 | 168459 | 0.050 |
Why?
|
Walking | 1 | 2009 | 1198 | 0.050 |
Why?
|
Indoles | 1 | 1990 | 1833 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 1998 | 4420 | 0.050 |
Why?
|
Colchicine | 1 | 2023 | 259 | 0.050 |
Why?
|
Basal Ganglia Hemorrhage | 1 | 2001 | 8 | 0.050 |
Why?
|
Antigens, CD20 | 1 | 2022 | 200 | 0.050 |
Why?
|
Paraplegia | 1 | 2002 | 161 | 0.050 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2002 | 65 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10723 | 0.050 |
Why?
|
Drosophila Proteins | 1 | 1990 | 1699 | 0.050 |
Why?
|
Mental Recall | 1 | 2007 | 1214 | 0.050 |
Why?
|
Personality | 1 | 2005 | 554 | 0.050 |
Why?
|
Software | 1 | 2015 | 4434 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5821 | 0.050 |
Why?
|
Subarachnoid Hemorrhage | 2 | 1999 | 1033 | 0.050 |
Why?
|
Models, Psychological | 1 | 2005 | 828 | 0.050 |
Why?
|
Adrenoleukodystrophy | 1 | 2003 | 143 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2009 | 8002 | 0.050 |
Why?
|
Ultrasonography, Doppler | 1 | 2003 | 462 | 0.050 |
Why?
|
Blood-Brain Barrier | 1 | 2007 | 1027 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2022 | 3156 | 0.050 |
Why?
|
Peptides | 2 | 2011 | 4358 | 0.040 |
Why?
|
Antiviral Agents | 2 | 2004 | 3060 | 0.040 |
Why?
|
Personality Inventory | 1 | 2003 | 1019 | 0.040 |
Why?
|
Receptors, Opioid, kappa | 2 | 1992 | 138 | 0.040 |
Why?
|
Bell Palsy | 1 | 2000 | 39 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.040 |
Why?
|
Pulse | 1 | 2000 | 217 | 0.040 |
Why?
|
Hormones | 1 | 2004 | 869 | 0.040 |
Why?
|
Cyclophosphamide | 1 | 2005 | 2218 | 0.040 |
Why?
|
Plasminogen Activators | 1 | 2000 | 199 | 0.040 |
Why?
|
Thorax | 1 | 2002 | 555 | 0.040 |
Why?
|
Injections, Spinal | 2 | 1990 | 318 | 0.040 |
Why?
|
Intracranial Embolism | 1 | 2001 | 189 | 0.040 |
Why?
|
Acoustic Stimulation | 1 | 2004 | 1235 | 0.040 |
Why?
|
Brain Edema | 1 | 2004 | 604 | 0.040 |
Why?
|
Carotid Stenosis | 1 | 2007 | 860 | 0.040 |
Why?
|
Anticoagulants | 2 | 2008 | 4812 | 0.040 |
Why?
|
Piperazines | 1 | 1990 | 2523 | 0.040 |
Why?
|
Visual Perception | 1 | 2007 | 1387 | 0.040 |
Why?
|
Sleep Stages | 1 | 2003 | 694 | 0.040 |
Why?
|
Adaptation, Psychological | 1 | 2009 | 2629 | 0.040 |
Why?
|
Encephalitis, Viral | 1 | 1999 | 58 | 0.040 |
Why?
|
Immunotherapy | 2 | 2005 | 4652 | 0.040 |
Why?
|
Child, Preschool | 6 | 2006 | 42230 | 0.040 |
Why?
|
Prednisone | 1 | 2003 | 1563 | 0.040 |
Why?
|
Brain Abscess | 1 | 1999 | 120 | 0.040 |
Why?
|
Anemia, Sickle Cell | 1 | 2007 | 1063 | 0.040 |
Why?
|
Pulsatile Flow | 1 | 1999 | 321 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2021 | 641 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2002 | 664 | 0.040 |
Why?
|
Heterocyclic Compounds | 1 | 1999 | 246 | 0.040 |
Why?
|
Streptococcus | 1 | 1997 | 198 | 0.040 |
Why?
|
Anisotropy | 1 | 2021 | 1283 | 0.040 |
Why?
|
Evoked Potentials | 1 | 2003 | 1038 | 0.040 |
Why?
|
Cellulitis | 1 | 1999 | 209 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2018 | 379 | 0.030 |
Why?
|
Psychometrics | 2 | 2004 | 3065 | 0.030 |
Why?
|
Lithium | 1 | 2000 | 596 | 0.030 |
Why?
|
Epilepsies, Partial | 1 | 2000 | 431 | 0.030 |
Why?
|
Plaque, Amyloid | 1 | 2001 | 760 | 0.030 |
Why?
|
Schools, Medical | 1 | 2003 | 879 | 0.030 |
Why?
|
Pentetic Acid | 1 | 1996 | 209 | 0.030 |
Why?
|
Hearing Loss | 1 | 2003 | 783 | 0.030 |
Why?
|
Attention | 2 | 2004 | 2396 | 0.030 |
Why?
|
Mental Disorders | 1 | 1996 | 6845 | 0.030 |
Why?
|
Brain Chemistry | 1 | 2000 | 960 | 0.030 |
Why?
|
Meglumine | 1 | 1996 | 144 | 0.030 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 1999 | 290 | 0.030 |
Why?
|
Antimanic Agents | 1 | 2000 | 520 | 0.030 |
Why?
|
Glioblastoma | 1 | 1991 | 3482 | 0.030 |
Why?
|
Accidental Falls | 1 | 2004 | 1068 | 0.030 |
Why?
|
Quadriplegia | 1 | 1997 | 226 | 0.030 |
Why?
|
Antioxidants | 1 | 2004 | 1668 | 0.030 |
Why?
|
Spine | 1 | 2002 | 1118 | 0.030 |
Why?
|
Epilepsy, Generalized | 1 | 1998 | 178 | 0.030 |
Why?
|
Spinal Cord Compression | 1 | 1997 | 235 | 0.030 |
Why?
|
Genome, Human | 1 | 2008 | 4425 | 0.030 |
Why?
|
Fever | 1 | 2003 | 1618 | 0.030 |
Why?
|
Depressive Disorder | 2 | 2009 | 3728 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1527 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 1998 | 1157 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2001 | 1164 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2002 | 2696 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2017 | 492 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2020 | 1258 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2477 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 1996 | 681 | 0.030 |
Why?
|
Hypertrophy | 1 | 1996 | 561 | 0.030 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 1990 | 894 | 0.030 |
Why?
|
Tomography, Optical Coherence | 1 | 2008 | 2917 | 0.030 |
Why?
|
Lymphoma | 1 | 2004 | 1901 | 0.030 |
Why?
|
Central Nervous System Stimulants | 1 | 2003 | 1177 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 2002 | 1010 | 0.030 |
Why?
|
Rats | 4 | 1992 | 23742 | 0.030 |
Why?
|
Language | 1 | 2004 | 1540 | 0.030 |
Why?
|
Heparin | 1 | 2001 | 1634 | 0.030 |
Why?
|
Membrane Proteins | 1 | 1990 | 7856 | 0.030 |
Why?
|
Sex Factors | 1 | 2007 | 10552 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2003 | 1809 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2016 | 847 | 0.030 |
Why?
|
Disease Management | 1 | 2004 | 2508 | 0.030 |
Why?
|
Steroids | 1 | 2018 | 929 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1440 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2449 | 0.030 |
Why?
|
Hemoglobins | 1 | 1999 | 1525 | 0.030 |
Why?
|
Dominance, Cerebral | 2 | 2007 | 623 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2008 | 2707 | 0.030 |
Why?
|
Age of Onset | 2 | 2011 | 3305 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2002 | 2161 | 0.030 |
Why?
|
Silver Staining | 1 | 1992 | 62 | 0.030 |
Why?
|
Chronic Disease | 2 | 2008 | 9318 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9469 | 0.030 |
Why?
|
Smoking | 1 | 2009 | 9053 | 0.030 |
Why?
|
Child | 5 | 2006 | 80153 | 0.020 |
Why?
|
Infusions, Parenteral | 1 | 1992 | 397 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2014 | 605 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2001 | 2084 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 8529 | 0.020 |
Why?
|
Length of Stay | 2 | 2002 | 6425 | 0.020 |
Why?
|
Prefrontal Cortex | 1 | 2002 | 2219 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2007 | 4527 | 0.020 |
Why?
|
Societies, Medical | 1 | 2003 | 3905 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2057 | 0.020 |
Why?
|
Age Factors | 1 | 2007 | 18395 | 0.020 |
Why?
|
Drug Combinations | 1 | 1996 | 2048 | 0.020 |
Why?
|
Functional Laterality | 2 | 2009 | 2257 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1827 | 0.020 |
Why?
|
Transfection | 1 | 2018 | 5774 | 0.020 |
Why?
|
Hemodynamics | 1 | 2000 | 4159 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2901 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1612 | 0.020 |
Why?
|
Stereoisomerism | 1 | 1990 | 614 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 1997 | 3595 | 0.020 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2009 | 71 | 0.020 |
Why?
|
Computer Simulation | 2 | 2016 | 6240 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12059 | 0.020 |
Why?
|
Europe | 1 | 2016 | 3422 | 0.020 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2009 | 98 | 0.020 |
Why?
|
Risk Factors | 6 | 2021 | 74206 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4278 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2526 | 0.020 |
Why?
|
Environmental Pollutants | 1 | 2018 | 1277 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1990 | 1141 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5821 | 0.020 |
Why?
|
Normal Distribution | 1 | 2009 | 272 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2011 | 5247 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4544 | 0.020 |
Why?
|
Adenoma | 1 | 1999 | 2160 | 0.020 |
Why?
|
Bed Rest | 1 | 2008 | 83 | 0.020 |
Why?
|
Equipment Design | 1 | 2016 | 3510 | 0.020 |
Why?
|
Staining and Labeling | 1 | 1992 | 1085 | 0.020 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 2007 | 63 | 0.020 |
Why?
|
Peptide Fragments | 2 | 1990 | 5112 | 0.020 |
Why?
|
Hindlimb | 1 | 1990 | 513 | 0.020 |
Why?
|
Administration, Rectal | 1 | 2007 | 70 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2009 | 504 | 0.020 |
Why?
|
Serotonin | 1 | 1992 | 1041 | 0.020 |
Why?
|
Ejaculation | 1 | 2007 | 59 | 0.020 |
Why?
|
Narcotic Antagonists | 1 | 1992 | 585 | 0.020 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2009 | 326 | 0.020 |
Why?
|
Brain Infarction | 1 | 2009 | 290 | 0.020 |
Why?
|
Infant | 3 | 2004 | 36192 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2002 | 7407 | 0.020 |
Why?
|
Interferon Type I | 1 | 2011 | 562 | 0.020 |
Why?
|
Mice | 3 | 2021 | 81525 | 0.020 |
Why?
|
Paresis | 1 | 2008 | 176 | 0.020 |
Why?
|
Enema | 1 | 2007 | 141 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10508 | 0.020 |
Why?
|
Papilledema | 1 | 2008 | 130 | 0.020 |
Why?
|
Coitus | 1 | 2007 | 132 | 0.020 |
Why?
|
Glucose | 1 | 1998 | 4346 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2009 | 629 | 0.020 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2008 | 179 | 0.020 |
Why?
|
Gels | 1 | 2007 | 420 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2005 | 7879 | 0.020 |
Why?
|
Biopsy | 1 | 1998 | 6766 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2005 | 18252 | 0.020 |
Why?
|
Up-Regulation | 1 | 2014 | 4124 | 0.020 |
Why?
|
Unsafe Sex | 1 | 2007 | 238 | 0.020 |
Why?
|
Thrombophilia | 1 | 2008 | 305 | 0.020 |
Why?
|
United States | 3 | 2016 | 72334 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2001 | 10766 | 0.010 |
Why?
|
Semen | 1 | 2007 | 347 | 0.010 |
Why?
|
Coma | 1 | 2008 | 484 | 0.010 |
Why?
|
Mobility Limitation | 1 | 2008 | 408 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4003 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7396 | 0.010 |
Why?
|
Age Distribution | 1 | 2009 | 2880 | 0.010 |
Why?
|
Internship and Residency | 1 | 2003 | 5880 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2645 | 0.010 |
Why?
|
Pakistan | 1 | 2003 | 292 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 3065 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2007 | 1068 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2007 | 819 | 0.010 |
Why?
|
Electron Transport Complex II | 1 | 2002 | 53 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2007 | 2927 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9539 | 0.010 |
Why?
|
Personality Assessment | 1 | 2004 | 650 | 0.010 |
Why?
|
Succinate Dehydrogenase | 1 | 2002 | 145 | 0.010 |
Why?
|
Reaction Time | 1 | 2007 | 2082 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6534 | 0.010 |
Why?
|
Factor Analysis, Statistical | 1 | 2004 | 999 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2691 | 0.010 |
Why?
|
Mitochondria, Muscle | 1 | 2002 | 172 | 0.010 |
Why?
|
New York | 1 | 2003 | 874 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2011 | 2639 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3778 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1997 | 6346 | 0.010 |
Why?
|
Facial Muscles | 1 | 2000 | 159 | 0.010 |
Why?
|
Social Support | 1 | 2009 | 2171 | 0.010 |
Why?
|
Health Surveys | 1 | 2009 | 4061 | 0.010 |
Why?
|
Oxidoreductases | 1 | 2002 | 413 | 0.010 |
Why?
|
Collateral Circulation | 1 | 2000 | 294 | 0.010 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1999 | 139 | 0.010 |
Why?
|
Corpus Callosum | 1 | 2003 | 751 | 0.010 |
Why?
|
Cochlear Nerve | 1 | 2000 | 202 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6484 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 1992 | 11076 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2002 | 2561 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2002 | 666 | 0.010 |
Why?
|
Facial Nerve | 1 | 2000 | 277 | 0.010 |
Why?
|
Edema | 1 | 2002 | 766 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2001 | 916 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1997 | 6935 | 0.010 |
Why?
|
Gyrus Cinguli | 1 | 2004 | 1115 | 0.010 |
Why?
|
Muscle Weakness | 1 | 2000 | 412 | 0.010 |
Why?
|
Orbit | 1 | 2000 | 457 | 0.010 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2002 | 710 | 0.010 |
Why?
|
Prolactin | 1 | 1999 | 625 | 0.010 |
Why?
|
Health Status | 1 | 2009 | 4077 | 0.010 |
Why?
|
Catheterization | 1 | 2001 | 1428 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22169 | 0.010 |
Why?
|
Gene Expression | 1 | 2008 | 7581 | 0.010 |
Why?
|
Administration, Oral | 1 | 2003 | 4021 | 0.010 |
Why?
|
Dexamethasone | 1 | 2002 | 1948 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2006 | 26198 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2007 | 2578 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9420 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2003 | 2244 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 21353 | 0.010 |
Why?
|
Medicaid | 1 | 2003 | 2818 | 0.010 |
Why?
|
Hemorrhage | 1 | 2001 | 3424 | 0.010 |
Why?
|
Electroencephalography | 1 | 2004 | 6225 | 0.000 |
Why?
|
Mass Screening | 1 | 2003 | 5428 | 0.000 |
Why?
|
Brain Ischemia | 1 | 2000 | 3049 | 0.000 |
Why?
|
Bipolar Disorder | 1 | 2000 | 5092 | 0.000 |
Why?
|
Neoplasms | 1 | 2008 | 22170 | 0.000 |
Why?
|